07.04.2017 | Letter to the Editor
Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 7/2017
Einloggen, um Zugang zu erhalten